Hims & Hers warns it may stop selling compounded weight-loss drugs
Hims & Hers said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo Nordisk because its pathway to do so closed when the U.S. FDA declared Friday that the drug's shortage was over.
Patients report that GLP-1 drugs like Ozempic and Mounjaro reduce “food noise,” the constant mental chatter about eating.
A mother was arrested for allegedly supplying illicit drugs to inmates at a Northern California juvenile hall. On Feb. 19, a ...
You've probably seen the ads for GLP-1 drugs. It's a hormone that helps people lose weight, but the results are not ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...
Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range ...
Ozempic, Mounjaro and Wegovy may not be the lightbulb, jet airplane or internet, but their impact is expected to be so ...
Studies have shown GLP-1 medications have other health benefits, including lowering the risk of certain diseases and ...
A new study found that some medications could have the unintended benefit of reducing dementia risk, while others could increase the risk. A doctor comments on the findings.
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
Press Trust of India on MSN10m
SC stays order asking govt to procure drugs for patient with rare disorderThe Supreme Court has stayed in the interim a Kerala High Court order directing the Centre to provide an additional Rs 18 ...
SAN DIEGO (FOX 5/KUSI) — U.S. Border Patrol agents seized over 160 pounds of narcotics last week during two traffic stops.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback